Virtual assistant designed to support endocrinologists, internists, pediatricians, primary care physicians, and specialists in metabolic diseases in the diagnosis, treatment, and follow-up of various lipodystrophy syndromes, based on the most recent scientific evidence (AACE 2025, Endocrine Society, EAS) and clinical guidelines valid as of July 2025.
Content automatically generated by an artificial intelligence system.It may contain inaccuracies.